As previously described, LncRNA MALAT1 positively regulates inflammation [23–25] and previous work suggests that upregulation of LncRNA MALAT1 aggravates NLRP3-mediated pyroptotic cell death in multiple diseases, including diabetic atherosclerosis [26] and diabetic nephropathy [27]. Here, NLRP3 is linked to diabetic kidney disease.